euro adhoc: MediGene AG / MediGene Achieves Excellent Clinical Results With Polyphenon® E Ointment in European Phase 3 Trial (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried - San Diego, March 31, 2004. The German-American biotech company MediGene AG (Frankfurt, Prime Standard: MDG) has achieved excellent results in a European phase 3 trial of the ...
mehr